Cost-effectiveness implications of increasing the efficiency of the extended-release naltrexone induction process for the treatment of opioid use disorder: a secondary analysis.
Addiction
; 116(12): 3444-3453, 2021 12.
Article
in En
| MEDLINE
| ID: mdl-33950535
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Naltrexone
/
Opioid-Related Disorders
Type of study:
Health_economic_evaluation
/
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Aspects:
Patient_preference
Limits:
Humans
Country/Region as subject:
America do norte
Language:
En
Journal:
Addiction
Journal subject:
TRANSTORNOS RELACIONADOS COM SUBSTANCIAS
Year:
2021
Document type:
Article
Affiliation country:
United States
Country of publication:
United kingdom